Global Heparin Market Report, History and Forecast 2017-2028
Description
Global Heparin Market Report, History and Forecast 2017-2028
Report Scope
Due to the COVID-19 pandemic, the global Heparin market size was value at US$ 2,262.93 million in 2021 and is forecast to be a readjusted size of US$ 5,381.53 million by 2028 with a CAGR of 12.64% during the forecast period 2022-2028.
The global main manufacturers of Heparin include Hepalink, Changshan Pharm, Qianhong Bio-pharma, Opocrin, Pfizer, Aspen Oss, King-friend Biochemical Pharmaceutical, Bioibérica, and Dongcheng Biochemicals, etc. In 2021, the global six largest players have a share approximately 64.44% in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Heparin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin.
The Heparin market size, estimations, and forecasts are provided in terms of sales volume (Billion Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Heparin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heparin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
Market Segmentation
This report covers the Heparin segments by manufacturers, by Type, by Application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
By Company
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Nanjing King-friend Biochemical Pharmaceutical
Pfizer
Hebei Changshan Biochemical Pharmaceutical
Bioibérica
Qingdao Jiulong Biopharmaceutical
Changzhou Qianhong Biopharma
Dongying Tiandong Pharmaceutical
Opocrin
Hubei Enoray Biopharmaceutical
Yino Pharma
Cisen Pharmaceutical
Nanjing Xinbai Pharmaceutical
Sichuan Deebio Pharmaceutical
Segment by Type
Heparin Sodium
Heparin Calcium
Segment by Application
UFH
LMWH
By Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
India
Rest of APAC
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, Central & South America, Middle East & Africa.
Chapter Two: Detailed analysis of Heparin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Heparin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, Central & South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, Central & South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Findings and Conclusion
Report Scope
Due to the COVID-19 pandemic, the global Heparin market size was value at US$ 2,262.93 million in 2021 and is forecast to be a readjusted size of US$ 5,381.53 million by 2028 with a CAGR of 12.64% during the forecast period 2022-2028.
The global main manufacturers of Heparin include Hepalink, Changshan Pharm, Qianhong Bio-pharma, Opocrin, Pfizer, Aspen Oss, King-friend Biochemical Pharmaceutical, Bioibérica, and Dongcheng Biochemicals, etc. In 2021, the global six largest players have a share approximately 64.44% in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Heparin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin.
The Heparin market size, estimations, and forecasts are provided in terms of sales volume (Billion Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Heparin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heparin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
Market Segmentation
This report covers the Heparin segments by manufacturers, by Type, by Application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
By Company
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Nanjing King-friend Biochemical Pharmaceutical
Pfizer
Hebei Changshan Biochemical Pharmaceutical
Bioibérica
Qingdao Jiulong Biopharmaceutical
Changzhou Qianhong Biopharma
Dongying Tiandong Pharmaceutical
Opocrin
Hubei Enoray Biopharmaceutical
Yino Pharma
Cisen Pharmaceutical
Nanjing Xinbai Pharmaceutical
Sichuan Deebio Pharmaceutical
Segment by Type
Heparin Sodium
Heparin Calcium
Segment by Application
UFH
LMWH
By Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
India
Rest of APAC
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, Central & South America, Middle East & Africa.
Chapter Two: Detailed analysis of Heparin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Heparin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, Central & South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, Central & South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Findings and Conclusion
Table of Contents
131 Pages
- 1 Heparin Market Overview
- 1.1 Heparin Product Overview
- 1.2 Heparin Market Segment By Type
- 1.2.1 Heparin Sodium
- 1.2.2 Heparin Calcium
- 1.3 Global Heparin Market Size By Type
- 1.3.1 Global Heparin Market Size Overview By Type (2017-2028)
- 1.3.2 Global Heparin Historic Market Size Review By Type (2017-2022)
- 1.3.3 Global Heparin Forecasted Market Size By Type (2023-2028)
- 1.4 Key Regions Market Size Segment By Type
- 1.4.1 North America Heparin Sales Breakdown By Type (2017-2022)
- 1.4.2 Europe Heparin Sales Breakdown By Type (2017-2022)
- 1.4.3 Asia-pacific Heparin Sales Breakdown By Type (2017-2022)
- 1.4.4 Central & South America Heparin Sales Breakdown By Type (2017-2022)
- 1.4.5 Middle East And Africa Heparin Sales Breakdown By Type (2017-2022)
- 2 Heparin Market Competition By Company
- 2.1 Global Top Players By Heparin Sales (2019-2022)
- 2.2 Global Top Players By Heparin Revenue (2019-2022)
- 2.3 Global Top Players By Heparin Price (2019-2022)
- 2.4 Global Top Manufacturers Heparin Manufacturing Base Distribution
- 2.5 Heparin Market Competitive Situation And Trends
- 2.5.1 Heparin Market Concentration Rate (2019-2022)
- 2.5.2 Global 5 And 10 Largest Manufacturers By Heparin Sales And Revenue In 2021
- 2.6 Global Top Manufacturers By Company Type (Tier 1, Tier 2, And Tier 3) & (Based On The Revenue In Heparin As Of 2021)
- 2.7 Founded Date Of Key Heparin Manufacturers
- 2.8 Key Manufacturers Heparin Product Offered
- 3 Heparin Status And Outlook By Region
- 3.1 Global Heparin Market Size And Cagr By Region: 2017 Vs 2021 Vs 2028
- 3.2 Global Heparin Historic Market Size By Region
- 3.2.1 Global Heparin Sales In Volume By Region (2017-2022)
- 3.2.2 Global Heparin Sales In Value By Region (2017-2022)
- 3.2.3 Global Heparin Sales (Volume & Value), Price And Gross Margin (2017-2022)
- 3.3 Global Heparin Forecasted Market Size By Region
- 3.3.1 Global Heparin Sales In Volume By Region (2023-2028)
- 3.3.2 Global Heparin Sales In Value By Region (2023-2028)
- 3.3.3 Global Heparin Sales (Volume & Value), Price And Gross Margin (2023-2028)
- 4 Heparin By Application
- 4.1 Heparin Market Segment By Application
- 4.1.1 Ufh
- 4.1.2 Lmwh
- 4.2 Global Heparin Market Size By Application
- 4.2.1 Global Heparin Market Size Overview By Application (2017-2028)
- 4.2.2 Global Heparin Historic Market Size Review By Application (2017-2022)
- 4.2.3 Global Heparin Forecasted Market Size By Application (2023-2028)
- 4.3 Key Regions Market Size Segment By Application
- 4.3.1 North America Heparin Sales Breakdown By Application (2017-2022)
- 4.3.2 Europe Heparin Sales Breakdown By Application (2017-2022)
- 4.3.3 Asia-pacific Heparin Sales Breakdown By Application (2017-2022)
- 4.3.4 Central & South America Heparin Sales Breakdown By Application (2017-2022)
- 4.3.5 Middle East And Africa Heparin Sales Breakdown By Application (2017-2022)
- 5 North America Heparin By Country
- 5.1 North America Heparin Historic Market Size By Country
- 5.1.1 North America Heparin Sales In Volume By Country (2017-2022)
- 5.1.2 North America Heparin Sales In Value By Country (2017-2022)
- 5.2 North America Heparin Forecasted Market Size By Country
- 5.2.1 North America Heparin Sales In Volume By Country (2023-2028)
- 5.2.2 North America Heparin Sales In Value By Country (2023-2028)
- 6 Europe Heparin By Country
- 6.1 Europe Heparin Historic Market Size By Country
- 6.1.1 Europe Heparin Sales In Volume By Country (2017-2022)
- 6.1.2 Europe Heparin Sales In Value By Country (2017-2022)
- 6.2 Europe Heparin Forecasted Market Size By Country
- 6.2.1 Europe Heparin Sales In Volume By Country (2023-2028)
- 6.2.2 Europe Heparin Sales In Value By Country (2023-2028)
- 7 Asia-pacific Heparin By Region
- 7.1 Asia-pacific Heparin Historic Market Size By Region
- 7.1.1 Asia-pacific Heparin Sales In Volume By Region (2017-2022)
- 7.1.2 Asia-pacific Heparin Sales In Value By Region (2017-2022)
- 7.2 Asia-pacific Heparin Forecasted Market Size By Region
- 7.2.1 Asia-pacific Heparin Sales In Volume By Region (2023-2028)
- 7.2.2 Asia-pacific Heparin Sales In Value By Region (2023-2028)
- 8 Central & South America Heparin By Country
- 8.1 Central & South America Heparin Historic Market Size By Country
- 8.1.1 Central & South America Heparin Sales In Volume By Country (2017-2022)
- 8.1.2 Central & South America Heparin Sales In Value By Country (2017-2022)
- 8.2 Central & South America Heparin Forecasted Market Size By Country
- 8.2.1 Central & South America Heparin Sales In Volume By Country (2023-2028)
- 8.2.2 Central & South America Heparin Sales In Value By Country (2023-2028)
- 9 Middle East And Africa Heparin By Country
- 9.1 Middle East And Africa Heparin Historic Market Size By Country
- 9.1.1 Middle East And Africa Heparin Sales In Volume By Country (2017-2022)
- 9.1.2 Middle East And Africa Heparin Sales In Value By Country (2017-2022)
- 9.2 Middle East And Africa Heparin Forecasted Market Size By Country
- 9.2.1 Middle East And Africa Heparin Sales In Volume By Country (2023-2028)
- 9.2.2 Middle East And Africa Heparin Sales In Value By Country (2023-2028)
- 10 Company Profiles And Key Figures In Heparin Business
- 10.1 Shenzhen Hepalink Pharmaceutical
- 10.1.1 Shenzhen Hepalink Pharmaceutical Corporation Information
- 10.1.2 Shenzhen Hepalink Pharmaceutical Introduction And Business Overview
- 10.1.3 Shenzhen Hepalink Pharmaceutical Heparin Sales, Revenue And Gross Margin (2019-2022)
- 10.1.4 Shenzhen Hepalink Pharmaceutical Heparin Products Offered
- 10.2 Yantai Dongcheng Pharmaceutical
- 10.2.1 Yantai Dongcheng Pharmaceutical Corporation Information
- 10.2.2 Yantai Dongcheng Pharmaceutical Introduction And Business Overview
- 10.2.3 Yantai Dongcheng Pharmaceutical Heparin Sales, Revenue And Gross Margin (2019-2022)
- 10.2.4 Yantai Dongcheng Pharmaceutical Heparin Products Offered
- 10.3 Nanjing King-friend Biochemical Pharmaceutical
- 10.3.1 Nanjing King-friend Biochemical Pharmaceutical Corporation Information
- 10.3.2 Nanjing King-friend Biochemical Pharmaceutical Introduction And Business Overview
- 10.3.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales, Revenue And Gross Margin (2019-2022)
- 10.3.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Products Offered
- 10.4 Pfizer
- 10.4.1 Pfizer Corporation Information
- 10.4.2 Pfizer Introduction And Business Overview
- 10.4.3 Pfizer Heparin Sales, Revenue And Gross Margin (2019-2022)
- 10.4.4 Pfizer Heparin Products Offered
- 10.5 Hebei Changshan Biochemical Pharmaceutical
- 10.5.1 Hebei Changshan Biochemical Pharmaceutical Corporation Information
- 10.5.2 Hebei Changshan Biochemical Pharmaceutical Introduction And Business Overview
- 10.5.3 Hebei Changshan Biochemical Pharmaceutical Heparin Sales, Revenue And Gross Margin (2019-2022)
- 10.5.4 Hebei Changshan Biochemical Pharmaceutical Heparin Products Offered
- 10.6 Bioibérica
- 10.6.1 Bioibérica Corporation Information
- 10.6.2 Bioibérica Introduction And Business Overview
- 10.6.3 Bioibérica Heparin Sales, Revenue And Gross Margin (2019-2022)
- 10.6.4 Bioibérica Heparin Products Offered
- 10.7 Qingdao Jiulong Biopharmaceutical
- 10.7.1 Qingdao Jiulong Biopharmaceutical Corporation Information
- 10.7.2 Qingdao Jiulong Biopharmaceutical Introduction And Business Overview
- 10.7.3 Qingdao Jiulong Biopharmaceutical Heparin Sales, Revenue And Gross Margin (2019-2022)
- 10.7.4 Qingdao Jiulong Biopharmaceutical Heparin Products Offered
- 10.8 Changzhou Qianhong Biopharma
- 10.8.1 Changzhou Qianhong Biopharma Corporation Information
- 10.8.2 Changzhou Qianhong Biopharma Introduction And Business Overview
- 10.8.3 Changzhou Qianhong Biopharma Heparin Sales, Revenue And Gross Margin (2019-2022)
- 10.8.4 Changzhou Qianhong Biopharma Heparin Products Offered
- 10.9 Dongying Tiandong Pharmaceutical
- 10.9.1 Dongying Tiandong Pharmaceutical Corporation Information
- 10.9.2 Dongying Tiandong Pharmaceutical Introduction And Business Overview
- 10.9.3 Dongying Tiandong Pharmaceutical Heparin Sales, Revenue And Gross Margin (2019-2022)
- 10.9.4 Dongying Tiandong Pharmaceutical Heparin Products Offered
- 10.10 Opocrin
- 10.10.1 Opocrin Corporation Information
- 10.10.2 Opocrin Introduction And Business Overview
- 10.10.3 Opocrin Heparin Sales, Revenue And Gross Margin (2019-2022)
- 10.10.4 Opocrin Heparin Products Offered
- 10.11 Hubei Enoray Biopharmaceutical
- 10.11.1 Hubei Enoray Biopharmaceutical Corporation Information
- 10.11.2 Hubei Enoray Biopharmaceutical Introduction And Business Overview
- 10.11.3 Hubei Enoray Biopharmaceutical Heparin Sales, Revenue And Gross Margin (2019-2022)
- 10.11.4 Hubei Enoray Biopharmaceutical Heparin Products Offered
- 10.12 Yino Pharma
- 10.12.1 Yino Pharma Corporation Information
- 10.12.2 Yino Pharma Introduction And Business Overview
- 10.12.3 Yino Pharma Heparin Sales, Revenue And Gross Margin (2019-2022)
- 10.12.4 Yino Pharma Heparin Products Offered
- 10.13 Cisen Pharmaceutical
- 10.13.1 Cisen Pharmaceutical Corporation Information
- 10.13.2 Cisen Pharmaceutical Introduction And Business Overview
- 10.13.3 Cisen Pharmaceutical Heparin Sales, Revenue And Gross Margin (2019-2022)
- 10.13.4 Cisen Pharmaceutical Heparin Products Offered
- 10.14 Nanjing Xinbai Pharmaceutical
- 10.14.1 Nanjing Xinbai Pharmaceutical Corporation Information
- 10.14.2 Nanjing Xinbai Pharmaceutical Introduction And Business Overview
- 10.14.3 Nanjing Xinbai Pharmaceutical Heparin Sales, Revenue And Gross Margin (2019-2022)
- 10.14.4 Nanjing Xinbai Pharmaceutical Heparin Products Offered
- 10.15 Sichuan Deebio Pharmaceutical
- 10.15.1 Sichuan Deebio Pharmaceutical Corporation Information
- 10.15.2 Sichuan Deebio Pharmaceutical Introduction And Business Overview
- 10.15.3 Sichuan Deebio Pharmaceutical Heparin Sales, Revenue And Gross Margin (2019-2022)
- 10.15.4 Sichuan Deebio Pharmaceutical Heparin Products Offered
- 11 Upstream, Opportunities, Challenges, Risks And Influences Factors Analysis
- 11.1 Heparin Key Raw Materials
- 11.1.1 Key Raw Materials
- 11.1.2 Raw Materials Key Suppliers
- 11.2 Manufacturing Cost Structure
- 11.2.1 Raw Materials
- 11.2.2 Labor Cost
- 11.2.3 Manufacturing Expenses
- 11.3 Heparin Industrial Chain Analysis
- 11.4 Heparin Market Dynamics
- 11.4.1 Heparin Industry Trends
- 11.4.2 Heparin Market Drivers
- 11.4.3 Heparin Market Challenges
- 11.4.4 Heparin Market Restraints
- 12 Marketing Strategy Analysis, Distributors
- 12.1 Sales Channel
- 12.2 Heparin Distributors
- 12.3 Heparin Downstream Customers
- 13 Research Findings And Conclusion
- 14 Methodology And Data Source
- 14.1 Methodology/Research Approach
- 14.1.1 Research Programs/Design
- 14.1.2 Market Size Estimation
- 14.1.3 Market Breakdown And Data Triangulation
- 14.2 Data Source
- 14.2.1 Secondary Sources
- 14.2.2 Primary Sources
- 14.3 Author List
- 14.4 Disclaimer
- List Of Tables
- Table 1. Global Heparin Sales By Type: 2017 Vs 2021 Vs 2028 (Us$ Million)
- Table 2. Global Heparin Sales By Type (2017-2022) & (Billion Units)
- Table 3. Global Heparin Sales Market Share In Volume By Type (2017-2022)
- Table 4. Global Heparin Sales By Type (2017-2022) & (Us$ Million)
- Table 5. Global Heparin Sales Market Share In Value By Type (2017-2022)
- Table 6. Global Heparin Price By Type (2017-2022) & (Us$/Billion Units)
- Table 7. Global Heparin Sales By Type (2023-2028) & (Billion Units)
- Table 8. Global Heparin Sales Market Share In Volume By Type (2023-2028)
- Table 9. Global Heparin Sales By Type (2023-2028) & (Us$ Million)
- Table 10. Global Heparin Sales Market Share In Value By Type (2023-2028)
- Table 11. Global Heparin Price By Type (2023-2028) & (Us$/Billion Units)
- Table 12. North America Heparin Sales By Type (2017-2022) & (Billion Units)
- Table 13. Europe Heparin Sales (Billion Units) By Type (2017-2022)
- Table 14. Asia-pacific Heparin Sales (Billion Units) By Type (2017-2022)
- Table 15. Central & South America Heparin Sales (Billion Units) By Type (2017-2022)
- Table 16. Middle East And Africa Heparin Sales (Billion Units) By Type (2017-2022)
- Table 17. Global Heparin Sales By Company (2019-2022) & (Billion Units)
- Table 18. Global Heparin Sales Share By Company (2019-2022)
- Table 19. Global Heparin Revenue By Company (2019-2022) & (Us$ Million)
- Table 20. Global Heparin Revenue Share By Company (2019-2022)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
